Our MTC patients revealed a good correlation between LAT1/2 and GLUT1 expression levels, together with an increase in GLUT1 gene expression, though less marked than that of 18F-FDOPA transporters. The gene discussed is SLC7A5; the disease is medullary thyroid gland carcinoma.